XENE Q2 2023 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$56M

Net Income

-$47M

EPS (Diluted)

$-0.72

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$35M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$685M

Total Liabilities

$38M

Stockholders' Equity

$646M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$536,000	-100.0%
Gross Profit	$0	-$22M	+100.0%
Operating Income	-$56M	-$30M	-83.5%
Net Income	-$47M	-$31M	-52.3%